Seguimiento farmacoterapéutico en pacientes con hipertensión arterial no controlada y dislipidemia atendidos en un Hospital de Iquitos, año 2023

• Autores: Tello Gómez, Katherine Hann, Torres Meléndez, Kristhian Martin
• Formato: tesis de grado
• Fecha de Publicación: 2024
• Institución: Universidad Nacional De La Amazonía Peruana
• Repositorio: UNAPIquitos-Institucional
• Lenguaje: español
• OAI Identifier: oai:repositorio.unapiquitos.edu.pe:20.500.12737/10736
• Enlace del recurso: https://hdl.handle.net/20.500.12737/10736
• Nivel de acceso: acceso abierto
• Materia: Tratamiento farmacológico; Estudios de seguimiento; Hipertensión; Trastornos del metabolismo de los lípidos; https://purl.org/pe-repo/ocde/ford#3.01.05

Uncontrolled arterial hypertension and dyslipidemia are pathologies with a high risk of cardiovascular morbidity and mortality. The specific objectives were to identify the demographic characteristics, measure the efficacy of pharmacotherapeutic follow-up using the Morisky Green test in patients with uncontrolled hypertension and dyslipidemia, attended in the office of the Home Care Program -PADOMI of Hospital III- Iquitos, EsSalud 2023; quantitative study type, analytical, prospective, quasi-experimental design; the population was 69 patients with arterial hypertension and 41 patients with dyslipidemia; the methodology used was pharmacotherapeutic follow-up to determine drug-related problems - DRPs, Morisky-Green test, for adherence to treatment; the results obtained in both pathologies were more frequent in the female sex, ages between 27 to 59 years; the DRPs were: 70.8% DRP4 and 52.8% DRP5, therapeutic adherence with 66.7% in patients with uncontrolled arterial hypertension and 77.8% in patient with dyslipidemia. We conclude that pharmacotherapeutic follow-up contributes to improving adherence to drug treatment in patients with uncontrolled hypertension and dyslipidemia, improving the health of patients with both pathologies.